|
FDA Issues 48 Product-Specific Bioequivalence Guidances
The FDA has issued dozens of draft and revised draft product-specific guidances that detail its recommendations for bioequivalence (BE) studies to support ANDAs.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives